trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['breast', 'solid tumor', 'enhertu']
another exciting news drop from #asco23 this morning. the antibody drug conjugate enhertu, which wowed in breast cancer, made tumors shrink or disappear in 37% of patients with her2 expression in a wide range of solid tumors. has the details: 
Senior Science Correspondent for @Endpts covering biotech, drug discovery, gene editing, RNA and emerging tech in biomedicine. Formerly at Boston Globe and C&EN